Mulberry Leaf Extract Improves Metabolic Syndrome by Alleviating Lipid Accumulation In Vitro and In Vivo

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 16; p. 5111
• Main Authors: He, Liangyu, Xing, Yan, Ren, Xinxiu, Zheng, Mengjiao, Yu, Shiqiang, Wang, Yinbo, Xiu, Zhilong, Dong, Yuesheng
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.08.2022; MDPI
• Subjects: Accumulation; Analysis; Complications; Dextrose; Diabetes; Enzymes; Fatty acids; Flavonoids; Gene expression; Glucose; Glucose metabolism; gut microbiota; Hyperglycemia; In vivo methods and tests; Insulin; Insulin resistance; Intestinal microflora; Isoflavones; Kinases; Leaves; Lipid metabolism; Lipids; Lipogenesis; Liver; Medical research; Medicine, Botanic; Medicine, Experimental; Medicine, Herbal; Metabolic disorders; Metabolic syndrome; Metabolites; Microbiota; Microbiota (Symbiotic organisms); Monounsaturated fatty acids; mulberry leaf extract; Obesity; Oleic acid; Oxidation; Physiological aspects; Physiology; Plant extracts; Plasma; Proteins; Signal transduction; Transcription factors; Type 2 diabetes; China
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27165111

Metabolic syndrome (MS) is a metabolic disease with multiple complications. Mulberry leaf extract (MLE) is rich in flavonoids and has great potential in alleviating glucose and lipid metabolism disorders. This study evaluated the effect and mechanism of MLE on the alleviation of MS. The components of the MLE were analyzed, and then the regulation of lipid metabolism by MLE in vitro and in vivo was determined. In a hepatocyte model of oleic acid-induced lipid accumulation, it was found that MLE alleviated lipid accumulation and decreased the expression of genes involved in lipogenesis. Furthermore, MLE improved obesity, insulin resistance, plasma lipid profile, and liver function in MS mice after a 15-week intervention. MLE decreased the expression of SREBP1, ACC, and FAS through the AMPK signaling pathway to inhibit lipid synthesis and increase the level of CPT1A to promote lipid decomposition to achieve its hypolipidemic effect. Meanwhile, MLE was also shown to affect the composition of the gut microbiota and the production of short-chain fatty acids, which contributed to the alleviation of lipid accumulation. Our results suggest that MLE can improve MS by improving lipid metabolism through multiple mechanisms and can be developed into dietary supplements for the improvement of MS.